In a Cox proportional hazards analysis, with prerandomization
body mass index, site, and diagnostic subtype as covariates, there was no significant
difference between fluoxetine and placebo in time-to-relapse (hazard ratio, 1.12;
95% CI, 0.65-2.01; P=.64).